These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29695508)

  • 61. Profiling of Serum miRNAs Constructs a Diagnostic 3-miRNA Panel for Clear-Cell Renal Cell Carcinoma.
    Li X; Wen Z; Li R; Lu C; Chen W; Chen X; Huang G; Ni L; Lai Y; Tao L
    Clin Genitourin Cancer; 2024 Feb; 22(1):23-32. PubMed ID: 37574436
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration.
    Li H; Zhao J; Zhang JW; Huang QY; Huang JZ; Chi LS; Tang HJ; Liu GQ; Zhu DJ; Ma WM
    Neoplasma; 2013; 60(5):511-5. PubMed ID: 23790169
    [TBL] [Abstract][Full Text] [Related]  

  • 63. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 64. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.
    Hirata H; Ueno K; Nakajima K; Tabatabai ZL; Hinoda Y; Ishii N; Dahiya R
    Br J Cancer; 2013 May; 108(10):2070-8. PubMed ID: 23591200
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.
    Machackova T; Mlcochova H; Stanik M; Dolezel J; Fedorko M; Pacik D; Poprach A; Svoboda M; Slaby O
    Tumour Biol; 2016 Nov; 37(11):14653-14658. PubMed ID: 27619681
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma.
    Zhou L; Chen J; Li Z; Li X; Hu X; Huang Y; Zhao X; Liang C; Wang Y; Sun L; Shi M; Xu X; Shen F; Chen M; Han Z; Peng Z; Zhai Q; Chen J; Zhang Z; Yang R; Ye J; Guan Z; Yang H; Gui Y; Wang J; Cai Z; Zhang X
    PLoS One; 2010 Dec; 5(12):e15224. PubMed ID: 21253009
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
    [TBL] [Abstract][Full Text] [Related]  

  • 69. LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression.
    Deng H; Huang C; Wang Y; Jiang H; Peng S; Zhao X
    Aging (Albany NY); 2019 Aug; 11(16):5975-5991. PubMed ID: 31434797
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth.
    Dhyani A; Machado-Neto JA; Favaro P; Saad ST
    Eur J Cancer; 2015 Jan; 51(2):252-9. PubMed ID: 25483783
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.
    Fan B; Jin Y; Zhang H; Zhao R; Sun M; Sun M; Yuan X; Wang W; Wang X; Chen Z; Liu W; Yu N; Wang Q; Liu T; Li X
    Int J Oncol; 2020 Jan; 56(1):178-192. PubMed ID: 31789394
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis.
    Tang K; Xu H
    Sci Rep; 2015 May; 5():10272. PubMed ID: 25974855
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MiR-340 regulates the growth and metabolism of renal cell carcinoma cells by targeting frizzled class receptor 3.
    Xiang M; Huang Y; Dai C; Zou G
    Arch Pharm Res; 2021 Feb; 44(2):219-229. PubMed ID: 33609235
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.
    Wotschofsky Z; Liep J; Meyer HA; Jung M; Wagner I; Disch AC; Schaser KD; Melcher I; Kilic E; Busch J; Weikert S; Miller K; Erbersdobler A; Mollenkopf HJ; Jung K
    Int J Biol Sci; 2012; 8(10):1363-74. PubMed ID: 23139634
    [TBL] [Abstract][Full Text] [Related]  

  • 75. New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney.
    Zaravinos A; Lambrou GI; Mourmouras N; Katafygiotis P; Papagregoriou G; Giannikou K; Delakas D; Deltas C
    PLoS One; 2014; 9(3):e91646. PubMed ID: 24621579
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluating the Molecular Properties and Function of ANKHD1, and Its Role in Cancer.
    Mullenger JL; Zeidler MP; Fragiadaki M
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629022
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing.
    Osanto S; Qin Y; Buermans HP; Berkers J; Lerut E; Goeman JJ; van Poppel H
    PLoS One; 2012; 7(6):e38298. PubMed ID: 22745662
    [TBL] [Abstract][Full Text] [Related]  

  • 78. miR-124 and miR-203 synergistically inactivate EMT pathway via coregulation of ZEB2 in clear cell renal cell carcinoma (ccRCC).
    Chen J; Zhong Y; Li L
    J Transl Med; 2020 Feb; 18(1):69. PubMed ID: 32046742
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
    Munari E; Marchionni L; Chitre A; Hayashi M; Martignoni G; Brunelli M; Gobbo S; Argani P; Allaf M; Hoque MO; Netto GJ
    Hum Pathol; 2014 Jun; 45(6):1130-8. PubMed ID: 24703100
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting
    Meng L; Xing Z; Guo Z; Qiu Y; Liu Z
    Aging (Albany NY); 2021 Mar; 13(7):9613-9626. PubMed ID: 33742606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.